SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ASTM-AASTROM BIOSCIENCES: STEM CELL RESEARCH
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: JMarcus who wrote (23)11/20/1997 11:49:00 AM
From: pat w.  Read Replies (1) of 1084
 
11:03 ET Aastrom Biosciences (ASTM) 5 1/2 +3/4 (+16%): Company receives a patent for "Bioreactor for Mammalian Cell Growth and Maintenance," covering its cell culture chamber for the ex vivo production of human cells, including stem cells. The patent covers a device with specialized features and configurations to provide uniform human tissue or cell growth for large-scale clinical production
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News